/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Petros Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights

Petros Pharmaceuticals Inc share price today is $0.0356, up -46.45%. The stock opened at $0.0646 against the previous close of $0.124, with an intraday high of $0.085 and low of $0.0601.

Petros Pharmaceuticals Inc Share Price Chart

style
pb-0

Petros Pharmaceuticals Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Petros Pharmaceuticals Inc Share Price Performance

$0.0356 -0.4645(-46.45%) PTPI at 13 Mar 2026 02:53 PM Drug Manufacturers - Specialty & Generic
Lowest Today 0.0601
Highest Today 0.085
Today’s Open 0.0646
Prev. Close 0.124
52 Week High 17.00
52 Week Low 0.06
Day’s Range: Low 0.0601 High 0.085
52-Week Range: Low 0.06 High 17.00
1 day return -
1 Week return -
1 month return -
3 month return -
6 month return -
1 year return -24.31
3 year return -95.45
5 year return -99.81
10 year return -

Petros Pharmaceuticals Inc Institutional Holdings

Fidelity Extended Market Index 0.17

Geode Capital Management, LLC 0.07

Vanguard Group Inc 0.06

Vanguard Institutional Extnd Mkt Idx Tr 0.06

Fidelity Series Total Market Index 0.03

UBS Group AG 0.02

Northern Trust Extended Eq Market Idx 0.00

NT Ext Equity Mkt Idx Fd - L 0.00

Advisor Group Holdings, Inc. 0.00

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.00

NT Ext Eq Mkt Indx Fd DC Lend T3 0.00

NT Ext Eq Mkt Indx Fd DC Lend T4 0.00

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.00

NT Ext Equity Mkt Idx Fd - NL 0.00

Bank of America Corp 0.00

Blackstone Alternative Multi-Strategy I 0.00

Group One Trading, LP 0.00

Northern Trust Wilshire 5000 0.00

NT Quality SCC US Fund - L 0.00

NT Quality Small Cap Core 0.00

SSgA U.S. Total Market Index Strategy 0.00

BlackRock Inc 0.00

Morgan Stanley - Brokerage Accounts 0.00

Tower Research Capital LLC 0.00

TWO SIGMA SECURITIES, LLC 0.00

Petros Pharmaceuticals Inc Market Status

Strong Buy: 0

Buy: 1

Hold: 0

Sell: 0

Strong Sell: 0

Petros Pharmaceuticals Inc Fundamentals

Market Cap 0.27 M

PB Ratio 0.4465

PE Ratio 0.0

Enterprise Value -1.42 M

Total Assets 10.64 M

Volume 266556737

Petros Pharmaceuticals Inc Company Financials

Annual Revenue FY23:6984739 7.0M, FY22:5992054 6.0M, FY21:7811264 7.8M, FY20:9559469 9.6M, FY19:15577166 15.6M

Annual Profit FY23:4630334 4.6M, FY22:3702636 3.7M, FY21:6211698 6.2M, FY20:5513003 5.5M, FY19:8150055 8.2M

Annual Net worth FY23:-12702698 -12.7M, FY22:-27037573 -27.0M, FY21:-9355336 -9.4M, FY20:-20585925 -20.6M, FY19:-32511300 -32.5M

Quarterly Revenue Q1/2025:0 0.0M, Q3/2024:1576366 1.6M, Q2/2024:1421471 1.4M, Q1/2024:1388806 1.4M, Q4/2023:-364250 -0.4M

Quarterly Profit Q1/2025:null 0.0M, Q3/2024:1289361 1.3M, Q2/2024:1092361 1.1M, Q1/2024:1056975 1.1M, Q4/2023:-522397 -0.5M

Quarterly Net worth Q1/2025:-2260022 -2.3M, Q3/2024:-2220661 -2.2M, Q2/2024:-662026 -0.7M, Q1/2024:-8026944 -8.0M, Q4/2023:318150 0.3M

About Petros Pharmaceuticals Inc & investment objective

Company Information Petros Pharmaceuticals, Inc., a healthcare technology company, focuses on developing and licensing proprietary SaaS platform and Software as a medical device web application designed to assist pharmaceutical companies. The company is based in New York, New York.

Organisation Drug Manufacturers - Specialty & Generic

Employees 18

Industry Drug Manufacturers - Specialty & Generic

CEO null

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow